Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR2 | P30518 | 20/20 | 0.64 |
| ▸ | OXTR | P30559 | 8/20 | 0.49 |
| ▸ | AVPR1A | P37288 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4200901 | 0.92 | AVPR2 (0.75) | AVPR2OXTRAVPR1A | |
| SCHEMBL4204095 | 0.86 | AVPR2 (0.67) | AVPR2OXTRAVPR1A | |
| SCHEMBL4204092 | 0.85 | AVPR2 (0.64) | AVPR2OXTRAVPR1A | |
| SCHEMBL4198269 | 0.84 | AVPR2 (0.85) | AVPR2OXTR | |
| SCHEMBL4195589 | 0.77 | AVPR2 (1.00) | AVPR2 | |
| SCHEMBL4198538 | 0.76 | AVPR2 (0.81) | AVPR2OXTR | |
| SCHEMBL4204579 | 0.71 | AVPR2 (0.70) | AVPR2 | |
| SCHEMBL4932308 | 0.69 | AVPR2 (0.78) | AVPR2 | |
| SCHEMBL4206215 | 0.69 | AVPR2 (1.00) | AVPR2 | |
| SCHEMBL6202959 | 0.68 | AVPR2 (0.82) | AVPR2OXTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7560454-B2 | Condensed azepines as vasopressin agonists | VANTIA LIMITED (GB) | 2009-07-14 | — | — | US | claimed |
| EP-1248784-B1 | CONDENSED AZEPINES AS VASOPRESSIN AGONISTS | FERRING BV (NL) | 2007-07-11 | — | — | EP | claimed |
| US-20040038962-A1 | Fused azepine derivatives and their use as antidiuretic agents | VANTIA LIMITED (GB) | 2004-02-26 | — | — | US | claimed |
| US-20030087892-A1 | Condensed azepines as vasopressin agonists | VANTIA LIMITED (GB) | 2003-05-08 | — | — | US | claimed |
| US-7560454-B2 | Condensed azepines as vasopressin agonists | VANTIA LIMITED (GB) | 2009-07-14 | — | — | US | disclosed |
| US-20080261951-A1 | Condensed azepines as vasopressin agonists | ASHWORTH DOREEN MARY | 2008-10-23 | — | — | US | disclosed |
| EP-1248784-B1 | CONDENSED AZEPINES AS VASOPRESSIN AGONISTS | FERRING BV (NL) | 2007-07-11 | — | — | EP | disclosed |
| US-7176195-B2 | Fused azepine derivatives and their use as antidiuretic agents | FERRING BV (NL) | 2007-02-13 | — | — | US | disclosed |
| US-20060154916-A1 | Condensed azepines as vasopressin agonists | FERRING BV | 2006-07-13 | — | — | US | disclosed |
| US-7074781-B2 | Condensed azepines as vasopressin agonists | FERRING BV (NL) | 2006-07-11 | — | — | US | disclosed |
| US-20040038962-A1 | Fused azepine derivatives and their use as antidiuretic agents | VANTIA LIMITED (GB) | 2004-02-26 | — | — | US | disclosed |
| US-20030087892-A1 | Condensed azepines as vasopressin agonists | VANTIA LIMITED (GB) | 2003-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060154916-A1 | Condensed azepines as vasopressin agonists | AVPR2, AVPR1A, AVPR1B | AVPR2 1/4885OXTR 4/4885AVPR1A 2/4885 |
| US-20080261951-A1 | Condensed azepines as vasopressin agonists | AVPR2, AVPR1A, AVPR1B | AVPR2 1/4885OXTR 4/4885AVPR1A 2/4885 |
| US-20040038962-A1 | Fused azepine derivatives and their use as antidiuretic agents | AVPR2, AVPR1A, AVPR1B | AVPR2 1/4885OXTR 21/4885AVPR1A 2/4885 |
| US-20030087892-A1 | Condensed azepines as vasopressin agonists | AVPR2, AVPR1A, AVPR1B | AVPR2 1/4885OXTR 4/4885AVPR1A 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.